Family Communication Following BRCA1/2 Genetic Testing: A Close Look at the Process

被引:29
|
作者
Lafreniere, Darquise [1 ]
Bouchard, Karine [2 ,3 ]
Godard, Beatrice [1 ]
Simard, Jacques [4 ,5 ]
Dorval, Michel [2 ,3 ,6 ]
机构
[1] Univ Montreal, Fac Med, Dept Med Sociale & Prevent, Programmes Bioeth, Montreal, PQ H3C 3J7, Canada
[2] Hop St Sacrement, Ctr Rech CHU Quebec, Unite Rech Sante Populat, Quebec City, PQ, Canada
[3] Hop St Sacrement, CHU Quebec, Ctr Malad Sein Deschenes Fabia, Quebec City, PQ, Canada
[4] Univ Laval, Fac Med, Dept Med Mol, Quebec City, PQ G1K 7P4, Canada
[5] CHUL, Ctr Rech CHU Quebec, Lab Genom Canc, Quebec City, PQ, Canada
[6] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
基金
加拿大健康研究院;
关键词
Genes; BRCA1; BRCA2; Communication; Family; Genetic predisposition to disease; Psychosocial factors; CANCER-RISK ASSESSMENT; OVARIAN-CANCER; HEREDITARY BREAST; DECISION-MAKING; INFORMATION; RELATIVES; MUTATION; WOMEN; METHODOLOGY; NONCARRIERS;
D O I
10.1007/s10897-012-9559-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
This study examines the process of communicating BRCA1/2 genetic test results to family members, and the factors influencing disclosure. Twenty-nine semi-structured telephone interviews with BRCA1/2 tested individuals, 4 to 9 years post-notification, were conducted. Our results suggest that individual, familial, relational and socio-medical factors influence the decision to disclose/not disclose genetic test results to family members. These factors are at play in all three communication phases: the Decision-making phase, in which the individual ponders various factors before deciding to disclose test results to family members; the Disclosure phase, in which communication per se takes place; and the Reaction phase, which shapes the participant's subsequent disclosure/non-disclosure decisions. We propose a guiding framework to assist in identifying and evaluating significant factors that might shape the course and outcome of the transmission of genetic information to family members.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 50 条
  • [31] Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations
    DiGianni, LM
    Rue, M
    Emmons, K
    Garber, JE
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (01) : 70 - 75
  • [32] Long-term prophylactic surgery outcomes following BRCA1/2 genetic testing
    Graves, K. D.
    Gell, C. E.
    Hecker, S. L.
    Peshkin, B. N.
    Taylor, K. L.
    Schwartz, M. D.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) : 359 - 359
  • [33] Genetic testing for BRCA1 mutation in the UK
    Eccles, DM
    LANCET, 2003, 361 (9352): : 178 - 179
  • [34] Clinical implications of BRCA1 genetic testing
    Dorum, A
    Heimdal, K
    Moller, P
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1998, 77 (04) : 458 - 461
  • [35] Systematic review of educational tools used during the BRCA1/2 genetic testing process
    Dorval, Michel
    Bouchard, Karine
    Chiquette, Jocelyne
    PERSONALIZED MEDICINE, 2014, 11 (01) : 113 - 124
  • [36] Population-Based Genetic Testing for BRCA1 and BRCA2 Reply
    Childers, Christopher P.
    Childers, Kimberly K.
    Maggard-Gibbons, Melinda
    Macinko, James
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [37] Genetic testing for BRCA1 and BRCA2 mutations in the Hispanic population.
    Erlichman, J
    Valero, V
    Lu, K
    Rivera, E
    Strong, L
    Arun, B
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S166 - S166
  • [38] Intention to communicate BRCA1/BRCA2 genetic test results to the family
    Barsevick, Andrea M.
    Montgomery, Susan V.
    Ruth, Karen
    Ross, Eric A.
    Egleston, Brian L.
    Bingler, Ruth
    Malick, John
    Miller, Suzanne M.
    Cescon, Terrence P.
    Daly, Mary B.
    JOURNAL OF FAMILY PSYCHOLOGY, 2008, 22 (02) : 303 - 312
  • [39] Exploring family communication after receiving BRCA1/2 results
    Dancyger, Caroline
    Smith, J.
    Jacobs, C.
    Michie, S.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 : S30 - S30
  • [40] Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria
    Singer, C. F.
    Muhr, D.
    Rappaport, C.
    Tea, M-K
    Gschwantler-Kaulich, D.
    Fink-Retter, A.
    Pfeiler, G.
    Berger, A.
    Sun, P.
    Narod, S. A.
    CLINICAL GENETICS, 2014, 85 (01) : 72 - 75